An evidence-based intervention (Fit for Treatment”) to prevent cancer treatment-induced toxicities in cancer patients: An effectiveness-implementation hybrid study

Not Applicable

• Conditions: Any histologically-confirmed diagnosis of cancer; Fatigue; Cognitive Function; Chemotherapy-induced Peripheral Neuropathy; Cardiovascular Disease Risk; Cancer - Any cancer; Neurological - Other neurological disorders; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12618000596202
• Lead Sponsor: Tina Skinner

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-17
• Study Completion: 2022-04-21
• Last Update Posted: 3 October 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

>18 years of age
- Cancer patients prescribed any anti-cancer treatment
- >1 month post-surgery
- No co-morbid condition or falls risk that could prevent safe completion of the intervention
- Cognitively capable of consent

Exclusion Criteria

- Cancer patients prescribed any anti-cancer treatment
- Not planning to undergo surgery during the intervention period
- Any intellectual or physical disability which would make exercise intervention participation unsafe for the individual

Study & Design

• Study Type: Interventional
• Study Design: Not specified